What Moves Like TARS

Tarsus Pharmaceuticals, Inc. Biological Products, (No Diagnostic Substances) · Nasdaq

The tradable tickers whose daily moves track TARS most closely over the past year, filtered to risk comparable with TARS's own.

Closest match

SBIO ALPS Medical Breakthroughs ETF — 0.468 correlation over the past year, and 33% calmer than TARS.

251 sessions to 2026-09-10 · TARS volatility 46.7% annualised · $46.3M a day
Ticker 1-year correlation 3-year Volatility vs TARS Risk What it is
SBIO ALPS Medical Breakthroughs ETF
0.468
0.442 0.67× 33% calmer Fund
IONS Ionis Pharmaceuticals, Inc.
0.396
0.194 0.85× 15% calmer Pharmaceutical Preparations
IMNM Immunome, Inc.
0.363
0.282 1.46× 46% choppier Pharmaceutical Preparations
GMAB Genmab A/S
0.350
0.206 0.72× 28% calmer Pharmaceutical Preparations
ARVN Arvinas, Inc.
0.347
0.188 1.17× 17% choppier Pharmaceutical Preparations
TRVI Trevi Therapeutics, Inc.
0.347
0.139 1.28× 28% choppier Pharmaceutical Preparations
VKTX Viking Therapeutics, Inc.
0.344
0.319 1.28× 28% choppier Pharmaceutical Preparations
ARWR Arrowhead Pharmaceuticals, Inc.
0.344
0.212 1.30× 30% choppier Pharmaceutical Preparations
IDYA IDEAYA Biosciences, Inc.
0.338
0.299 0.98× similar Pharmaceutical Preparations
ASND Ascendis Pharma A/S - Ordinary Share
0.335
0.170 0.79× 21% calmer Pharmaceutical Preparations
KURA Kura Oncology, Inc.
0.334
0.243 1.30× 30% choppier Pharmaceutical Preparations
GERN Geron Corporation
0.333
0.165 1.38× 38% choppier Pharmaceutical Preparations
BLTE Belite Bio, Inc
0.330
0.163 1.18× 18% choppier Pharmaceutical Preparations
BCYC Bicycle Therapeutics plc
0.329
0.207 1.10× 10% choppier Pharmaceutical Preparations
MGTX MeiraGTx Holdings plc
0.327
0.252 1.28× 28% choppier Biological Products, (No Diagnostic Substances)
DCTH Delcath Systems, Inc.
0.325
0.130 1.12× 12% choppier Surgical & Medical Instruments & Apparatus
ZVRA Zevra Therapeutics, Inc.
0.324
0.204 1.36× 36% choppier Pharmaceutical Preparations
VERA Vera Therapeutics, Inc.
0.319
0.236 1.27× 27% choppier Pharmaceutical Preparations
RCUS Arcus Biosciences, Inc.
0.316
0.266 1.32× 32% choppier Pharmaceutical Preparations
PCVX Vaxcyte, Inc.
0.313
0.216 0.98× similar Biological Products, (No Diagnostic Substances)
BCRX BioCryst Pharmaceuticals, Inc.
0.311
0.240 1.04× similar Biological Products, (No Diagnostic Substances)
INSM Insmed Incorporated
0.311
0.147 1.33× 33% choppier Pharmaceutical Preparations
DNLI Denali Therapeutics Inc.
0.309
0.341 1.21× 21% choppier Biological Products, (No Diagnostic Substances)
SVRA Savara, Inc.
0.309
0.284 1.15× 15% choppier Pharmaceutical Preparations
ZYME Zymeworks Inc.
0.305
0.276 1.16× 16% choppier Pharmaceutical Preparations

Showing 25 of 26 tickers that qualified. Correlation is of daily returns; 1.000 would mean moving in lockstep, 0.000 no relationship at all.

What this is for

Three questions, one number behind all of them.

How to read the two correlation columns

The one-year figure is what the relationship looks like now. The three-year figure is what it has looked like over a longer stretch. Comparing them is the point: when they agree, the relationship is structural and likely to hold. When the one-year number is far below the three-year one, something has changed — a shift in business mix, an index reconstitution, a sector that has stopped moving together — and the recent figure is the one to trust less, not more.

Correlation measures whether two things move together, not whether they move by the same amount. That is why the volatility column is there. Two tickers can correlate at 0.99 while one swings half again as hard, and swapping one for the other would quietly change how much risk you are carrying.

What was deliberately left out

Ranking purely by correlation produces answers that are mathematically perfect and practically useless. The closest matches to AAPL by raw correlation are leveraged AAPL funds at 0.999 — correct, and not replacements for anything. Four filters run before a ticker is allowed to appear:

Where all of that leaves a ticker with no close match, the page says so. A stock with no substitute is a real and useful finding, and inventing a loose one to fill the table would be worse than an empty answer.

Limits, stated up front

Where the numbers come from

Correlations are computed in-house from a daily price history and rebuilt every night. What gets published is the derived statistic — a correlation coefficient, a volatility ratio, an observation count — and nothing from which a price or return series could be reconstructed. The rest of the Markets section is on the Markets overview, including futures positioning extremes and SEC Form 4 insider transactions.